India's Ministry of Health and Family Welfare has acknowledged that spurious or fake drugs are sensitive issues affecting the health of the citizens as well as the prestige of the country's pharmaceutical trade interests, and there is a sense of urgency in tackling the menace.
There is no dearth of good intentioned people who may wish to work for the country's interests as the whistle blowers - or informers - in eradicating the menace, the Ministry noted. People's participation is imperative in this regard and would be a highly effective step in augmenting the efforts of taking on the elements engaged in such illicit trade of spurious drugs, it said.
With this aim in view, a scheme has been devised by the Central Government for giving monetary rewards to the whistleblowers who are willing to take the risk of providing information about the perpetrators of such crimes. A similar scheme is already operating in other enforcement departments of government which has paid good dividend in terms of significant catches/seizures.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze